<DOC>
	<DOCNO>NCT02224053</DOCNO>
	<brief_summary>This Phase 1 , open-label , 2-period fixed sequence design evaluate interaction AZD9291 omeprazole approximately 50 healthy , adult male volunteer . Volunteers receive Treatment A ( AZD9291 omeprazole ) Period 1 Treatment B ( AZD9291 ) Period 2 . The dose AZD9291 Period 1 dose AZD9291 Period 2 separate washout least 21 day ( washout 5 week ) . The study perform 2 site USA ass effect omeprazole ( proton pump inhibitor ) AZD9291 exposure</brief_summary>
	<brief_title>Drug-Drug Interaction Study With AZD9291 Omeprazole Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Osimertinib</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>For inclusion study volunteer must fulfil follow criterion . 1 . Provision sign date informed consent prior studyspecific procedure . 2 . Healthy male volunteer age 18 55 year . ( Healthy determine medical history , physical examination , laboratory parameter , ECG , eye examination perform first administration investigational product . ) 3 . Body mass index 19 30 kg/m2 , body weight 50 kg 100 kg , inclusive . 4 . Veins suitable cannulation repeat venepuncture . 5 . Volunteers must willing use reliable method contraception ( condom spermicide ) , even partner postmenopausal , surgically sterile , use effective hormonal method contraception intrauterine coil . In addition , volunteer must agree continue take similar contraceptive precaution avoid sperm donation 6 month last administration AZD9291 . Volunteers must enter study follow exclusion criterion fulfil : 1 . Involvement plan and/or conduct study ( applies AstraZeneca Quintiles staff ) . 2 . Previous enrollment present study . 3 . History clinically significant disease disorder , opinion Investigator , may either put healthy volunteer risk participation study , influence result healthy volunteer 's ability participate study . 4 . History presence gastrointestinal , hepatic , renal disease surgical procedure condition know interfere absorption , distribution , metabolism , excretion drug . 5 . Any clinically significant abnormality physical examination , vital sign ( supine blood pressure &gt; 140 mmHg systolic , &gt; 90 mmHg diastolic , pulse rate ≤35 ≥100 beat per minute ) , clinical laboratory assessment judge Investigator . 6 . Acute illness , surgical procedure , trauma within 2 week enrollment first administration investigational product ( IP ) . 7 . Volunteers receive live liveattenuated vaccine 2 week prior dose . 8 . Volunteers active malignancy neoplastic disease previous 12 month . 9 . A suspected/manifested infection accord International Airline Transportation Association ( IATA ) Categories A B infectious substance . 10 . Positive result screen test serum hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody , human immunodeficiency virus ( HIV ) . 11 . Any clinically important abnormality rhythm , conduction , morphology rest ECG , judge Investigator . 12 . Known suspected history significant drug abuse judge Investigator . 13 . Positive screen drug abuse cotinine ( nicotine level 400 ng/mL ) screen positive screen alcohol , drug abuse , cotinine admission Period 1 Period 2 . 14 . History alcohol abuse excessive intake alcohol , define regular weekly intake great 21 unit alcohol men ( Note : 1 unit=25 mL spirit , 125 mL wine , 250 mL beer lager ) . 15 . History severe allergy/hypersensitivity ongoing allergy/hypersensitivity , judge Investigator , history hypersensitivity AZD9291 , excipients , drug similar chemical structure class . 16 . History hypersensitivity omeprazole , excipients , drug similar chemical structure class . 17 . Use prescribed nonprescribed medication , include drug hepatic enzymealtering property , St John 's Wort , antacid , analgesic , herbal remedy , vitamin , mineral 4 week ( longer depend medication 's halflife ) prior first administration AZD9291 permit . Occasional use paracetamol ( acetaminophen ) nonsteroidal nasal decongestant permit discretion Investigator . 18 . Any intake grapefruit , grapefruit juice , Seville oranges , Seville orange marmalade , product contain grapefruit Seville oranges within 7 day first administration IP . 19 . Blood donation within 1 month screen blood donation/blood loss great 500 mL 3 month prior screen . 20 . Use another new chemical entity ( define compound approve marketing ) participation clinical study ( include methodology study drug give ) within 3 month first administration IP study . 21 . Current smoker smoke used nicotine product within previous 3 month . 22 . Planned inpatient surgery , dental procedure , hospitalisation study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>oncology , cancer , non small cell lung cancer , anticancer druge , omeprazole , healthy volunteer</keyword>
</DOC>